165 related articles for article (PubMed ID: 32876523)
1. Potential biomarkers and risk assessment models to enhance the tumor-node-metastasis (TNM) staging classification of urologic cancers.
Darrell CM; Montironi R; Paner GP
Expert Rev Mol Diagn; 2020 Sep; 20(9):921-932. PubMed ID: 32876523
[TBL] [Abstract][Full Text] [Related]
2. Updates in the Eighth Edition of the Tumor-Node-Metastasis Staging Classification for Urologic Cancers.
Paner GP; Stadler WM; Hansel DE; Montironi R; Lin DW; Amin MB
Eur Urol; 2018 Apr; 73(4):560-569. PubMed ID: 29325693
[TBL] [Abstract][Full Text] [Related]
3. Is the TNM staging system for breast cancer still relevant in the era of biomarkers and emerging personalized medicine for breast cancer - an institution's 10-year experience.
Orucevic A; Chen J; McLoughlin JM; Heidel RE; Panella T; Bell J
Breast J; 2015; 21(2):147-54. PubMed ID: 25600504
[TBL] [Abstract][Full Text] [Related]
4. The updated points of TNM classification of urological cancers in the 8th edition of AJCC and UICC.
Kandori S; Kojima T; Nishiyama H
Jpn J Clin Oncol; 2019 May; 49(5):421-425. PubMed ID: 30844068
[TBL] [Abstract][Full Text] [Related]
5. TNM: evolution and relation to other prognostic factors.
Sobin LH
Semin Surg Oncol; 2003; 21(1):3-7. PubMed ID: 12923909
[TBL] [Abstract][Full Text] [Related]
6. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging.
Amin MB; Greene FL; Edge SB; Compton CC; Gershenwald JE; Brookland RK; Meyer L; Gress DM; Byrd DR; Winchester DP
CA Cancer J Clin; 2017 Mar; 67(2):93-99. PubMed ID: 28094848
[TBL] [Abstract][Full Text] [Related]
7. New and important changes in breast cancer TNM: incorporation of biologic factors into staging.
Edge SB; Hortobagyi GN; Giuliano AE
Expert Rev Anticancer Ther; 2019 Apr; 19(4):309-318. PubMed ID: 30759347
[TBL] [Abstract][Full Text] [Related]
8. Prognostication in eye cancer: the latest tumor, node, metastasis classification and beyond.
Kivelä T; Kujala E
Eye (Lond); 2013 Feb; 27(2):243-52. PubMed ID: 23258307
[TBL] [Abstract][Full Text] [Related]
9. TNM: principles, history, and relation to other prognostic factors.
Sobin LH
Cancer; 2001 Apr; 91(8 Suppl):1589-92. PubMed ID: 11309755
[TBL] [Abstract][Full Text] [Related]
10. New and Important Changes in the TNM Staging System for Breast Cancer.
Hortobagyi GN; Edge SB; Giuliano A
Am Soc Clin Oncol Educ Book; 2018 May; 38():457-467. PubMed ID: 30231399
[TBL] [Abstract][Full Text] [Related]
11. Breast Cancer-Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual.
Giuliano AE; Connolly JL; Edge SB; Mittendorf EA; Rugo HS; Solin LJ; Weaver DL; Winchester DJ; Hortobagyi GN
CA Cancer J Clin; 2017 Jul; 67(4):290-303. PubMed ID: 28294295
[TBL] [Abstract][Full Text] [Related]
12. Whither TNM?
Gönen M; Weiser MR
Semin Oncol; 2010 Feb; 37(1):27-30. PubMed ID: 20172361
[TBL] [Abstract][Full Text] [Related]
13. [The 1992 TNM classification of T2 prostate cancer predicts pathologic stage and prognosis better than the revised 1997 classification].
Koh H; Maru N; Muramoto M; Wheeler TM; Scardino PT; Ohori M
Nihon Hinyokika Gakkai Zasshi; 2002 Jul; 93(5):595-601. PubMed ID: 12174634
[TBL] [Abstract][Full Text] [Related]
14. Upper urinary tract urothelial carcinoma and its variants: transition from morphology to personalized molecular characterization in diagnosis, prognosis, and therapy.
Cimadamore A; Scarpelli M; Santoni M; Cheng L; Lopez-Beltran A; Montironi R
Expert Rev Mol Diagn; 2018 Dec; 18(12):1021-1028. PubMed ID: 30452305
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the current AJCC-TNM numeric-based with a new anatomical location-based lymph node staging system for gastric cancer: A western experience.
Galizia G; Lieto E; Auricchio A; Cardella F; Mabilia A; Diana A; Castellano P; De Vita F; Orditura M
PLoS One; 2017; 12(4):e0173619. PubMed ID: 28380037
[TBL] [Abstract][Full Text] [Related]
16. Prognostic nomogram for patients with Nasopharyngeal Carcinoma incorporating hematological biomarkers and clinical characteristics.
Li J; Chen S; Peng S; Liu Y; Xing S; He X; Chen H
Int J Biol Sci; 2018; 14(5):549-556. PubMed ID: 29805306
[TBL] [Abstract][Full Text] [Related]
17. Liquid biopsy: a step forward towards precision medicine in urologic malignancies.
Di Meo A; Bartlett J; Cheng Y; Pasic MD; Yousef GM
Mol Cancer; 2017 Apr; 16(1):80. PubMed ID: 28410618
[TBL] [Abstract][Full Text] [Related]
18. Non-coding RNAs as biomarkers in liquid biopsies with a special emphasis on extracellular vesicles in urological malignancies.
Zeuschner P; Linxweiler J; Junker K
Expert Rev Mol Diagn; 2020 Feb; 20(2):151-167. PubMed ID: 31499007
[No Abstract] [Full Text] [Related]
19. How can biomarkers assist the prognosis of urologic malignancies?
Falzarano SM; Feely MM
Expert Rev Mol Diagn; 2020 Feb; 20(2):131-133. PubMed ID: 31495243
[No Abstract] [Full Text] [Related]
20. Impact of biomarkers and genetic profiling on breast cancer prognostication: A comparative analysis of the 8th edition of breast cancer staging system.
Yoon EC; Schwartz C; Brogi E; Ventura K; Wen H; Darvishian F
Breast J; 2019 Sep; 25(5):829-837. PubMed ID: 31197914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
